Prostate Cancer Screenings

Confused about prostate cancer screening? Looking for information you can trust? You've come to the right place.

New Image

Our next FREE Screening* will be on November 7, 2017 at 231 N. Broad Street in Philadelphia. Call to schedule (215) 762-3200.

Prostate cancer is the most common cancer among men, and the second-leading cause of cancer death in men. Currently, the PSA (prostate-specific antigen) blood test is the best first-line test for prostate cancer, especially when combined with a physical exam of the prostate known as a digital rectal exam (DRE). Before the PSA was developed, prostate cancer was usually found after it had spread, when it was much harder to treat.

While the PSA test has limitations, we believe that when combined with a DRE and interpreted appropriately, it provides important information in the diagnosis, pre-treatment staging or risk assessment and monitoring of prostate cancer. These tests enable us to establish a baseline PSA level and to find prostate cancer at its earliest stages - while it is still confined to the prostate and has not spread to other parts of the body.

Whether or not to undergo a PSA test is a decision you should make with your doctor. Together, we will review your risk factors (age, race, family and personal history) and the pros and cons of screening. We believe in the value of prostate cancer screening and subsequent testing under the right circumstances. Not every man needs to be screened; not every man who has an elevated PSA level needs a biopsy; not every man with prostate cancer needs treatment.

We stay on top of the research so you can have the benefit of an open and frank discussion with knowledgeable experts. Research at this time shows a significant drop in prostate cancer deaths since the introduction of PSA and DRE screening. The American Urologic Association recommends men age 55 to 69 talk with a doctor about prostate cancer screening. Men who are African-American, smokers or have a family history should start the discussion sooner. Don't put off talking about whether screening is right for you.

*Research compiled by the American Urological Association, www.auanet.org.